Detalhe da pesquisa
1.
Circulating Tumor Cell Subtypes and T-cell Populations as Prognostic Biomarkers to Combination Immunotherapy in Patients with Metastatic Genitourinary Cancer.
Clin Cancer Res
; 27(5): 1391-1398, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262136
2.
Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors.
J Clin Oncol
; 38(31): 3672-3684, 2020 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32915679